|
|
TQL-1055 |
|
Vaxjo ID |
199 |
|
Vaccine Adjuvant Name |
TQL-1055 |
|
Adjuvant VO ID |
VO_0005283
|
|
Description |
semi synthetic analogue of QS-21that induces Th1 reponse |
|
Stage of Development |
Clinical Trial |
|
Location Licensed |
US (Adjuvance) |
|
Host Species for Testing |
2 |
|
Second Host Species for Testing |
6 |
|
Storage |
-20C |
|
Function |
presumably same as QS-21 in absence of dose-limiting toxicity |
| References |
(Martin, 2024): Vaccine Adjuvant Compendium - VAC [https://vac.niaid.nih.gov/view?id=36]
|
|
